Nordic Bioscience

Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform

placeHerlev, Capital Region Of Denmark, Denmark calendar_todayFounded 1996 groups336 employees language nordicbioscience.com

Innovation

106 patent families (36 granted) — focus: Physics & computing, Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 5,441 times.

YearFilings
20154
201615
20179
201813
201913
202017
202110
202216
202317
202422
202530
20269

Social engagement

Social engagement: 24K social following, 3 posts in the last 12 months — around the industry typical range.

Investor mix

2 investors on record; lead investors include KKR.

Investor typeCountShare
Private equity150%
Other / undisclosed150%

Recent activity

30 Jun 2026
Milestone
regulatory
16 Jun 2026
Event
ECM2026
Coming soon